Jonathan Lim, Co-Lead of The Manchester Immuno-Oncology Network (MION) and Lead of The Christie International Fellowship Program for Medical Oncology at The Christie NHS Foundation Trust, shared a post on LinkedIn:
“Really looking forward to catching up with colleagues and friends at ESMOImmuno25 in London over the next few days.
If you’re attending, please stop by our team’s poster – presented by our Specialist Clinical Trials Pharmacist Ragini Jethra and Senior Clinical Research Fellow Dr. Rachel Woodford. We highlight new insights from our systematic review on the safety profile of TIL therapy across solid tumours.”
More posts from ESMOImmuno25.